Total Payments
$24,969
2024 Payments
$2,044
Companies
44
Transactions
979
Medicare Patients
6,001
Medicare Billing
$705,645
Payment Breakdown by Category
Food & Beverage$13,442 (53.8%)
Other$8,020 (32.1%)
Travel$2,984 (12.0%)
Education$522.85 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,442 | 955 | 53.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $8,000 | 3 | 32.0% |
| Travel and Lodging | $2,984 | 6 | 12.0% |
| Education | $522.85 | 14 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $8,342 | 192 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $5,880 | 29 | $0 (2017) |
| ABBVIE INC. | $2,369 | 177 | $0 (2024) |
| Janssen Biotech, Inc. | $2,203 | 136 | $0 (2024) |
| Celgene Corporation | $709.91 | 66 | $0 (2024) |
| Gilead Sciences, Inc. | $543.48 | 40 | $0 (2024) |
| PFIZER INC. | $533.82 | 40 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $488.04 | 37 | $0 (2024) |
| RedHill Biopharma Inc. | $326.30 | 27 | $0 (2024) |
| GENZYME CORPORATION | $306.76 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,044 | 139 | Janssen Biotech, Inc. ($369.95) |
| 2023 | $1,927 | 134 | Janssen Biotech, Inc. ($418.79) |
| 2022 | $2,036 | 140 | Janssen Biotech, Inc. ($557.84) |
| 2021 | $2,115 | 162 | AbbVie Inc. ($455.82) |
| 2020 | $1,182 | 75 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($337.18) |
| 2019 | $1,369 | 104 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($773.87) |
| 2018 | $7,177 | 108 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($6,214) |
| 2017 | $7,120 | 117 | Valeant Pharmaceuticals North America LLC ($5,880) |
All Payment Transactions
979 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: LIVER DISEASE | ||||||
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Education | In-kind items and services | $8.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Immunology | ||||||
| 12/14/2024 | Hologic Sales and Service, LLC | CoolSeal Generator (Device) | Food and Beverage | In-kind items and services | $90.91 | General |
| Category: Surgical | ||||||
| 12/14/2024 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Surgery | ||||||
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.71 | General |
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: LIVER DISEASE | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.95 | General |
| 11/27/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,644 | 1,782 | $1.6M | $202,308 |
| 2022 | 16 | 1,500 | 1,637 | $1.4M | $176,713 |
| 2021 | 16 | 1,549 | 1,733 | $1.5M | $192,289 |
| 2020 | 14 | 1,308 | 1,472 | $1.1M | $134,335 |
Total Patients
6,001
Total Services
6,624
Medicare Billing
$705,645
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 365 | $127,385 | $37,936 | 29.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 158 | 159 | $301,703 | $33,404 | 11.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 206 | 214 | $341,330 | $19,283 | 5.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 143 | 143 | $62,920 | $18,859 | 30.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 148 | 149 | $270,435 | $16,021 | 5.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 66 | 66 | $111,804 | $12,744 | 11.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 146 | 190 | $43,700 | $12,632 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $34,144 | $8,119 | 23.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 41 | 41 | $69,454 | $7,758 | 11.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 62 | $27,156 | $6,881 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 97 | $22,795 | $6,698 | 29.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $69,454 | $5,997 | 8.6% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 18 | 18 | $41,400 | $5,015 | 12.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 51 | $16,932 | $4,973 | 29.4% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 25 | 25 | $9,086 | $2,338 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $9,474 | $2,219 | 23.4% |
| 43450 | Dilation of esophagus | Facility | 2023 | 22 | 23 | $28,750 | $788.89 | 2.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,573 | $433.82 | 27.6% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 14 | 15 | $27,225 | $208.40 | 0.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 298 | 382 | $133,318 | $38,175 | 28.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 133 | 134 | $254,265 | $28,607 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 180 | 180 | $79,200 | $21,367 | 27.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 210 | 218 | $347,710 | $19,374 | 5.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 127 | 127 | $230,505 | $12,933 | 5.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 130 | 164 | $37,720 | $9,914 | 26.3% |
About Dr. William Basri, M.D
Dr. William Basri, M.D is a Gastroenterology healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992778948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Basri, M.D has received a total of $24,969 in payments from pharmaceutical and medical device companies, with $2,044 received in 2024. These payments were reported across 979 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($13,442).
As a Medicare-enrolled provider, Basri has provided services to 6,001 Medicare beneficiaries, totaling 6,624 services with total Medicare billing of $705,645. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brick, NJ
- Active Since 02/09/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1992778948
Products in Payments
- XIFAXAN (Drug) $11,208
- STELARA (Biological) $1,836
- ZEPOSIA (Drug) $681.38
- XELJANZ (Drug) $507.25
- HUMIRA (Biological) $500.08
- DUPIXENT (Biological) $450.48
- RINVOQ (Biological) $337.37
- TRULANCE (Drug) $320.79
- LINZESS (Drug) $304.50
- Talicia (Drug) $302.26
- Trulance (Drug) $298.08
- XIFAXANIBSD (Drug) $279.93
- UCERIS (Drug) $252.37
- SKYRIZI (Biological) $228.16
- Alinia Tablets 500mg 30 count bottle (Drug) $217.25
- Humira (Biological) $216.37
- MAVYRET (Drug) $209.75
- TREMFYA (Drug) $208.87
- DIFICID (Drug) $197.85
- REMICADE (Biological) $191.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brick
Dr. Mark Cerefice, M.d, M.D
Gastroenterology — Payments: $24,872
Gastroenterology $24,872
Mr. Arkady Broder, Md, MD
Gastroenterology — Payments: $20,023
Gastroenterology $20,023
Kenny Chiu, Md, MD
Gastroenterology — Payments: $14,263
Gastroenterology $14,263
Dr. Kenny Hui, M.d, M.D
Gastroenterology — Payments: $14,084
Gastroenterology $14,084
Dr. Matthew Tangorra, D.o, D.O
Gastroenterology — Payments: $14,049
Gastroenterology $14,049
Dr. Neal Winzelberg, Md, MD
Gastroenterology — Payments: $9,650
Gastroenterology $9,650